Oscar Health, Inc.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
OSCR$33.47+4.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Operations
| Three Months Ended March 31, | ||
|---|---|---|
| (in thousands, except per share amounts) | 2026 | 2025 |
| Revenue | ||
| Premium | $4,580,862 | $2,995,821 |
| Investment income | 60,614 | 46,112 |
| Other revenues | 5,718 | 4,330 |
| Total revenue | 4,647,194 | 3,046,263 |
| Operating Expenses | ||
| Medical | 3,229,857 | 2,259,651 |
| Selling, general, and administrative | 706,234 | 482,759 |
| Depreciation and amortization | 7,018 | 6,730 |
| Total operating expenses | 3,943,109 | 2,749,140 |
| Earnings from operations | 704,085 | 297,123 |
| Interest expense | 5,383 | 5,994 |
| Other expenses (income) | (71) | 2,918 |
| Earnings before income taxes | 698,773 | 288,211 |
| Income tax expense | 19,750 | 12,705 |
| Net income | 679,023 | 275,506 |
| Less: Net income attributable to noncontrolling interests | 27 | 235 |
| Net income attributable to Oscar Health, Inc. | $678,996 | $275,271 |
| Earnings per Share | ||
| Basic | $2.28 | $1.10 |
| Diluted | $2.07 | $0.92 |
| Weighted Average Common Shares Outstanding | ||
| Basic | 298,184 | 251,279 |
| Diluted | 329,751 | 305,938 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.